Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 1191 to 1200

APO-IRBESARTAN HCTZ 300mg/25mg irbesartan / hydrochlorothiazide 300 mg/25 mg tablet bottle Cancelled under s30(1)(c) of the Act

5 April 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-IRBESARTAN HCTZ 300mg/12.5mg irbesartan / hydrochlorothiazide 300 mg/12.5 mg tablet bottle Cancelled under s30(1)(c) of the Act

5 April 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
GENRX IRBESARTAN HCTZ 300mg/12.5mg irbesartan / hydrochlorothiazide 300 mg/12.5 mg tablet blister pack Cancelled under s30(1)(c) of the Act

5 April 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
BLOOMS THE CHEMIST Paracetamol 500mg and Codeine 10mg tablet blister pack Cancelled under s30(1)(c)

28 March 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
BLOOMS THE CHEMIST Paracetamol 500mg and Codeine 10mg tablet blister pack Cancelled under s30(1)(c) of the Act

28 March 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-BOSENTAN bosentan (as monohydrate) 62.5mg tablets bottle Cancelled under s30(1)(c)

21 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-BOSENTAN bosentan (as monohydrate) 125mg tablets bottle Cancelled under s30(1)(c)

21 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 25 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 50 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 116
Page 117
Page 118
Page 119
Current page 120
Page 121
Page 122
Page 123
Page 124
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.